Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Motor Activity 9Neoplasms 7Breast Neoplasms 6Pancreatic Neoplasms 3Malnutrition 3Laryngeal Neoplasms 3Head and Neck Neoplasms 3Prostatic Neoplasms 2Pharyngeal Neoplasms 2Obesity 2Lung Neoplasms 2Liver Neoplasms 2Diabetes Mellitus, Type 2 2Colorectal Neoplasms 2Colonic Neoplasms 2Weight Loss 1Undefined 1Stomach Neoplasms 1Skin Neoplasms 1Sarcopenia 1Rectal Neoplasms 1Pancreatitis, Chronic 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neurotoxicity Syndromes 1Mouth Neoplasms 1Lung Diseases 1Liver Diseases 1Hypopharyngeal Neoplasms 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 87fludarabine 74Tacrolimus 45fludarabine phosphate 44Mycophenolic Acid 42Whole-Body Irradiation 41Busulfan 35Melphalan 31Antilymphocyte Serum 24thymoglobulin 22Methotrexate 22Rituximab 21Standard of Care 20Sirolimus 20Azacitidine 20venetoclax 19Thiotepa 19Stem Cell Transplantation 18Granulocyte Colony-Stimulating Factor 18Practice Guidelines as Topic 16Cytarabine 16Nivolumab 15Filgrastim 15Dexamethasone 14Cyclosporine 13Bortezomib 13Mesna 12Peripheral Blood Stem Cell Transplantation 11trametinib 10Specimen Handling 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hematologic Neoplasms × Nutritional Status × Clear all
NCT07173166 2026-03-10

CARE-T

Instituto de Investigacion Sanitaria INCLIVA

Phase NA Recruiting
100 enrolled
Other hematologic neoplasm

Motor Activity, Hematologic Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡